Colitis After CAR T-Cell Therapy for Refractory Large B-Cell Lymphoma Responds to Anti-Integrin Therapy

Inflamm Bowel Dis. 2021 Mar 15;27(4):e45-e46. doi: 10.1093/ibd/izaa320.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Colitis* / etiology
  • Humans
  • Immunotherapy, Adoptive / adverse effects*
  • Integrins / antagonists & inhibitors*
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy

Substances

  • Integrins